drugset / Trial / NCT02205606
Efficacy/Safety of HCP1306 Tablet Versus HGP0816 Tablet in Patients With Primary Hypercholesterolemia
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate efficacy and safety of HCP1306 in patients with primary hypercholesterolemia.
Timeline
- Start
- 2014-06
- Primary completion
- 2015-02
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ezetimibe | Unknown | 10 mg | Oral |
| Subject | Rosuvastatin | Small molecule | 5 mg | Oral |
| Subject | Rosuvastatin | Small molecule | 10 mg | Oral |
| Subject | Rosuvastatin | Small molecule | 20 mg | Oral |